Today we will analyze the stock Nabi Biopharmaceuticals (NABI) for internet stock trading in the NASDAQ stock market,
Stock Technical indicators to notice in Nabi Biopharmaceuticals (NABI)
1- Last bearish trend was from 5.50 $ (1/14/2010) to 4.85 $ (2/4/2010) a 0.65 $ move 2- The current bullish trend started from 4.85 $ at 2/4/2010 and is currently trading at 5.86 $.
3- NABI current support level is at 5.68 which is the 127.20 % fibonacci retracement of the last 0.65 $ move.
4- NABI current resistance level is at 5.90 which is the 161.80 % fibonacci retracement of the last 0.65 $ move.
5- According to ADX Indicator, the trend is currently bullish, which is getting stronger.furthermore, the ADX indicator location between DMI+ and DMI- is hinting on a strong move ahead. the stock is very volatile at this point.
Nabi Biopharmaceuticals (NABI) Short term stock chart patterns for internet stock trading :

6- The Stock was supported by a support line, identified by two points: 4.850 and 4.820, and is currently supporting at 4.881.
Nabi Biopharmaceuticals (NABI) Mid term stock chart patterns for internet stock trading :

7- The Stock was supported by a support line, identified by two points: 4.850 and 4.820, and is currently supporting at 4.881.
Nabi Biopharmaceuticals (NABI) Long term stock chart patterns for internet stock trading :

8- The Stock was supported by a support line, identified by two points: 4.850 and 4.680, and is currently supporting at 4.937.

Stock Trading Conclusion:
Nabi Biopharmaceuticals (NABI) was trading in a bullish wave, which is becoming stronger .
Technical indicators and stock chart patterns show highly volatile movements favoriting no favorited direction,
recommend hold or waiting for entry , because of the high expected future volatility, consider constructing symmetrical options strategies for buying volatility through strangles or straddles in online trading. .

Stock Resistance Levels : 5.90.
Stock Support levels : 5.68, 5.62, 5.50, 5.47, 5.36, 5.25, 5.24, 5.18, 5.10, 5.00, 4.94, 4.88, 4.85,.


Welcome to Nabi Biopharmaceuticals - an emerging global
Nabi Biopharmaceuticals is focused on developing and marketing products that address unmet medical needs and offer commercial opportunities in our core

NABI: Summary for Nabi Biopharmaceuticals- Yahoo! Finance
Mar 17, 2010 Get detailed information on Nabi Biopharmaceuticals (NABI) including quote performance, Real-Time ECN, technical chart analysis, key stats,

Nabi Biopharmaceuticals logs revenue from Glaxo sale - Washington
Nabi Biopharmaceuticals realized $10.5 million in revenue in its fiscal fourth quarter after collecting development payments from GlaxoSmithKline PLC for

Top Picks for 2010: Nabi Biopharmaceuticals (NABI) - BloggingStocks
Jan 5, 2010 "Nabi Biopharmaceuticals (NABI) is a small $250 million market cap company has a unique product with obvious benefits for a giant market,"

Hot Stocks in nasdaq market

  • Today
  • Week
  • Month